標(biāo)題: Titlebook: Endocrine Therapy of Breast Cancer V; A. Goldhirsch Conference proceedings 1992 Springer-Verlag Berlin Heidelberg 1992 Breast cancer.Brust [打印本頁(yè)] 作者: Fuctionary 時(shí)間: 2025-3-21 17:47
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V影響因子(影響力)
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V被引頻次
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V被引頻次學(xué)科排名
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V年度引用
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V年度引用學(xué)科排名
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V讀者反饋
書(shū)目名稱(chēng)Endocrine Therapy of Breast Cancer V讀者反饋學(xué)科排名
作者: 抵消 時(shí)間: 2025-3-21 20:52 作者: 推測(cè) 時(shí)間: 2025-3-22 01:18 作者: overbearing 時(shí)間: 2025-3-22 05:21 作者: 是他笨 時(shí)間: 2025-3-22 10:16
The Multi-Drug Resistance Phenotype and its Reversal by Drugs (with Special Emphasis on Anti-OestroMulti-drug resistance (MDR) is an unfortunate term, since it implies resistance to a wide range of drugs. In fact the origin of the MDR phenomenon is the preclinical observation of cross resistance to a specific group of natural products, particularly anthracyclines, vinca alkaloids and epipodophyllotoxins.作者: innate 時(shí)間: 2025-3-22 13:30 作者: innate 時(shí)間: 2025-3-22 18:21 作者: 闡釋 時(shí)間: 2025-3-22 23:18
https://doi.org/10.1007/978-94-011-4197-0nstrated in the haemopoietic system where the subclassification of leukaemias achieved in this way has led to a more objective approach to disease management and therapy. The success of the approach has depended on 3 major factors, namely, 1) the availability of specific immunological markers (monoc作者: 記憶法 時(shí)間: 2025-3-23 02:39 作者: abolish 時(shí)間: 2025-3-23 06:52
Alisa Von Hagel,Daniela Mansbachduce the growth rate of some breast cancers was confirmed by Stanley Boyd [2] who found improvement in approximately one-third of patients. This result has been adequately supported throughout this century but it is now clear that any hormonal therapy will affect the growth rate of about one-third o作者: SPALL 時(shí)間: 2025-3-23 10:23 作者: MUT 時(shí)間: 2025-3-23 14:03
Immunologie der Reproduktion im Kontext,current disease. As the incidence of breast cancer continues to rise, the interest in finding new characteristics associated with good versus poor prognosis is increasing. While the literature abounds with reports of potentially interesting tumour markers, in most clinical settings the traditional p作者: 夸張 時(shí)間: 2025-3-23 18:53 作者: subordinate 時(shí)間: 2025-3-23 22:57 作者: Boycott 時(shí)間: 2025-3-24 03:13 作者: 單調(diào)女 時(shí)間: 2025-3-24 07:28
978-3-642-77664-9Springer-Verlag Berlin Heidelberg 1992作者: 改正 時(shí)間: 2025-3-24 11:10
https://doi.org/10.1007/978-3-031-44176-9t Cancer Oestrogen Induced), which has been extensively characterised. It was studied not only as a means of predicting response to hormone therapy in advanced breast cancer, but also as a predictor of outcome in early cancer and as a model of oestrogen regulation of a human target gene.作者: Terminal 時(shí)間: 2025-3-24 18:42 作者: attenuate 時(shí)間: 2025-3-24 20:19 作者: 預(yù)測(cè) 時(shí)間: 2025-3-24 23:33
Prognostic Factors in Primary Breast Cancer: Second Thoughts,ical tumour markers currently gaining recognition as a prognostic factor, one still finds dissent in the literature as to whether steroid hormone receptor determinations are useful and how they should be implemented in the clinical management of primary breast cancer.作者: Formidable 時(shí)間: 2025-3-25 06:34
Conference proceedings 1992motherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has 作者: commodity 時(shí)間: 2025-3-25 10:09 作者: 吼叫 時(shí)間: 2025-3-25 15:10 作者: Lyme-disease 時(shí)間: 2025-3-25 19:10 作者: 壓倒性勝利 時(shí)間: 2025-3-25 20:38 作者: 組裝 時(shí)間: 2025-3-26 02:14 作者: blight 時(shí)間: 2025-3-26 05:54
https://doi.org/10.1007/978-3-211-69916-4occult micrometastatic disease already present at the time of diagnosis and first surgery [1]. This hypothesis has acquired indirect support from the results of clinical trials which showed no additional advantage in terms of disease-free or overall survival for a more radical local therapy [2,3].作者: 蝕刻術(shù) 時(shí)間: 2025-3-26 11:54 作者: 使出神 時(shí)間: 2025-3-26 16:27
Endometrium und Embryo – Interaktiongens and proteoglycans) influence a variety of fundamental cellular attributes. The mechanism by which the ECM exerts these different effects appears to depend upon the interaction of matrix macromolecules with specific cell surface receptors resulting in alterations in the organisation of the cytoskeleton and consequent changes in cell shape [4].作者: 似少年 時(shí)間: 2025-3-26 19:17 作者: 不能逃避 時(shí)間: 2025-3-26 22:37
Reproductive Health and Maternal Sacrificeresistance to therapeutic agents, new treatments, the patient with breast cancer, her quality of life, and some public health issues related to the population of women with the disease. The Monograph provides summaries of some of the discussed topics and reflects the stimulating atmosphere during the Task Force meeting.作者: NAUT 時(shí)間: 2025-3-27 04:46 作者: 集合 時(shí)間: 2025-3-27 06:34
Introduction,resistance to therapeutic agents, new treatments, the patient with breast cancer, her quality of life, and some public health issues related to the population of women with the disease. The Monograph provides summaries of some of the discussed topics and reflects the stimulating atmosphere during the Task Force meeting.作者: originality 時(shí)間: 2025-3-27 10:02 作者: extrovert 時(shí)間: 2025-3-27 14:04
Do All Roads Lead to the Oestrogen Receptor?,t has been adequately supported throughout this century but it is now clear that any hormonal therapy will affect the growth rate of about one-third of advanced breast cancer in either pre- or postmenopausal women.作者: Spina-Bifida 時(shí)間: 2025-3-27 21:02 作者: Isolate 時(shí)間: 2025-3-28 01:16
https://doi.org/10.1007/978-94-011-4197-0lonal antibodies) to define differentiation-related antigens, 2) the easy availability of circulating blood cells and 3) the development of culture systems where primitive and more differentiated progenitor cells could be cultured and induced to clonally differentiate.作者: 謙虛的人 時(shí)間: 2025-3-28 02:13
The Second Pillar: The Surgical Team, precious. Even modest treatment effects will influence the outcome for a large number of women. For node-negative disease, modest but important improvements in treatment efficacy may go undetected, and/or a much longer time may be required to identify an effective treatment.作者: 瑣碎 時(shí)間: 2025-3-28 07:16 作者: painkillers 時(shí)間: 2025-3-28 11:56 作者: confide 時(shí)間: 2025-3-28 18:38 作者: 一條卷發(fā) 時(shí)間: 2025-3-28 21:42 作者: 笨拙的我 時(shí)間: 2025-3-29 01:49 作者: single 時(shí)間: 2025-3-29 05:48
Prognostic Factors in Primary Breast Cancer: Second Thoughts,current disease. As the incidence of breast cancer continues to rise, the interest in finding new characteristics associated with good versus poor prognosis is increasing. While the literature abounds with reports of potentially interesting tumour markers, in most clinical settings the traditional p作者: 并置 時(shí)間: 2025-3-29 10:02 作者: 阻礙 時(shí)間: 2025-3-29 13:55 作者: Horizon 時(shí)間: 2025-3-29 16:22 作者: dearth 時(shí)間: 2025-3-29 23:06 作者: MURKY 時(shí)間: 2025-3-30 03:12
Steuerungsprobleme der Raumplanungozialismus) nie einen hohen politischen Stellenwert erreicht. Die dringenden Notwendigkeiten des wirtschaftlichen und gesellschaftlichen Wiederaufbaus (der als ?Restauration“ ?lterer Strukturen keiner planenden Gestaltung zu bedürfen schien), aber auch der dogmatisierte Glaube an die Selbststeuerung作者: 銼屑 時(shí)間: 2025-3-30 04:54
